ASX:1AIPharmaceuticals, Biotechnology & Life SciencesBiotechnology
ALGORAE PHARMACEUTICALS ORD
$0.018
Day Range
$0.018 - $0.018
52 Week Range
$0.005 - $0.024
Volume
136.51K
Avg Volume (10D)
1.40M
Market Cap
$30.90M
Price Chart
Market Statistics
Open$0.018
Previous Close$0.018
Day High$0.018
Day Low$0.018
52 Week High$0.024
52 Week Low$0.005
Valuation
Market Cap30.90M
Shares Outstanding1.72B
Price to Book16.08
Trading Activity
Volume136.51K
Value Traded2.46K
Bid$0.017 × 1,193,230
Ask$0.018 × 612,906
Performance
1 Day5.88%
5 Day20.00%
13 Week28.57%
52 Week260.00%
YTD28.57%
Technical Indicators
RSI (14)58.64
50-Day SMA$0.018
200-Day SMA$0.012
Latest News
Biotechnology
Algorae Pharmaceuticals Enters Second Drug Synergy Screening Program with Peter MacCallum Cancer Centre
Algorae launches second AOS2 synergy program with Peter MacCallum Cancer Centre's VCFG; 24 drug combos across cancers; six-month preclinical data.
1 min read
Biotechnology
Algorae Pharmaceuticals Partners with Cadila to Market Two New Medicines in Australia and NZ
Algorae inks Cadila deal to market two cardio/metabolic generics in Australia & NZ; Cadila develops/manufactures; AlgoraeRx handles regulatory and marketing.
1 min read
Biotechnology
Algorae Pharmaceuticals Advances Commercial Pathway as AI Platform Validation and Distribution Agreements Gather Pace
Algorae Pharmaceuticals (ASX: 1AI) advances AlgoraeOS validation and signs Dr Reddy's distribution, signals near-term oncology revenue and stronger balance sheet.
2 min read
Biotechnology
Algorae Pharmaceuticals Identifies 90 New Drug-Combination Candidates from AlgoraeOS V2 Analysis
Algorae Pharmaceuticals (ASX: 1AI) has identified 90 high-quality drug-combination candidates following a preliminary review of newly delivered in silico synergy predictions generated by its upgraded AlgoraeOS v2 platform.
1 min read